Show simple item record

dc.contributor.authorWoodman, Ciaran B J
dc.contributor.authorGibbs, Alan R
dc.contributor.authorScott, N
dc.contributor.authorHaboubi, Najib
dc.contributor.authorCollins, S
dc.date.accessioned2009-10-13T09:02:15Z
dc.date.available2009-10-13T09:02:15Z
dc.date.issued2001-09-14
dc.identifier.citationAre differences in stage at presentation a credible explanation for reported differences in the survival of patients with colorectal cancer in Europe? 2001, 85 (6):787-90 Br. J. Canceren
dc.identifier.issn0007-0920
dc.identifier.pmid11556824
dc.identifier.doi10.1054/bjoc.2001.1958
dc.identifier.urihttp://hdl.handle.net/10541/84122
dc.description.abstractPopular reporting of a comparison of cancer survival rates across 17 European countries, based on data collected by national and regional cancer registries, has left an impression of inadequate treatment of patients in the UK. A subsequent study has suggested that the poor survival rates reported for the UK can, in large part, be explained by more advanced stage at presentation. We believe this conclusion to be unsound and use this study as an example to illustrate the methodological difficulties which may arise during such international comparisons. As the NHS cancer plan aspires to achieve for the UK parity with the best cancer care in Europe, careful thought needs to be given to identifying countries with which the UK can usefully compare itself and the most appropriate indicators for this comparison.
dc.language.isoenen
dc.subjectColorectal Canceren
dc.subjectCancer Stagingen
dc.subject.meshAdenocarcinoma
dc.subject.meshAge Factors
dc.subject.meshColorectal Neoplasms
dc.subject.meshEurope
dc.subject.meshGreat Britain
dc.subject.meshHumans
dc.subject.meshNeoplasm Staging
dc.subject.meshRegistries
dc.subject.meshSurvival Rate
dc.titleAre differences in stage at presentation a credible explanation for reported differences in the survival of patients with colorectal cancer in Europe?en
dc.typeArticleen
dc.contributor.departmentCentre for Cancer Epidemiology, University of Manchester, Christie Hospital NHS Trust, Kinnaird Road, Withington, Manchester M20 4QL, UK.en
dc.identifier.journalBritish Journal of Canceren
refterms.dateFOA2020-04-22T12:15:06Z
html.description.abstractPopular reporting of a comparison of cancer survival rates across 17 European countries, based on data collected by national and regional cancer registries, has left an impression of inadequate treatment of patients in the UK. A subsequent study has suggested that the poor survival rates reported for the UK can, in large part, be explained by more advanced stage at presentation. We believe this conclusion to be unsound and use this study as an example to illustrate the methodological difficulties which may arise during such international comparisons. As the NHS cancer plan aspires to achieve for the UK parity with the best cancer care in Europe, careful thought needs to be given to identifying countries with which the UK can usefully compare itself and the most appropriate indicators for this comparison.


Files in this item

Thumbnail
Name:
89120.pdf
Size:
210.2Kb
Format:
PDF
Description:
From UNPAYWALL

This item appears in the following Collection(s)

Show simple item record